Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ONE WORLD PEDIATRICS

NPI: 1467891531 · LONGWOOD, FL 32750 · Pediatric Adolescent Medicine Physician · NPI assigned 06/21/2013

$4.84M
Total Medicaid Paid
137,230
Total Claims
112,043
Beneficiaries
78
Codes Billed
2019-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialAMBWANI, JAGDISH (CEO)
NPI Enumeration Date06/21/2013

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 17,404 $689K
2020 15,919 $641K
2021 17,285 $872K
2022 23,382 $1.13M
2023 39,443 $946K
2024 23,797 $567K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 20,804 17,539 $1.62M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 10,943 9,899 $1.27M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4,121 3,996 $566K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 4,350 3,775 $499K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2,228 2,126 $255K
90460 Immunization administration through 18 years of age via any route, first or only component 11,758 7,880 $139K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 701 682 $90K
90461 7,866 4,158 $56K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 6,215 3,160 $51K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2,455 2,359 $50K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 778 632 $46K
90670 2,029 1,965 $43K
99460 457 431 $41K
99188 2,575 2,479 $23K
92552 586 543 $17K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2,773 2,659 $17K
99238 Hospital discharge day management, 30 minutes or less 173 159 $6K
90698 1,561 1,511 $5K
99221 39 38 $5K
90677 112 109 $4K
99381 28 25 $3K
99462 236 191 $3K
96127 2,234 2,027 $3K
90716 720 707 $3K
96110 Developmental screening, with scoring and documentation, per standardized instrument 852 810 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 562 522 $2K
99383 12 12 $2K
90651 136 130 $2K
87807 296 285 $2K
0071A 63 57 $2K
99050 197 192 $2K
90696 103 99 $1K
0072A 57 55 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 166 119 $1K
99463 12 12 $1K
99174 4,095 3,651 $890.21
90686 1,074 1,044 $786.08
90707 702 686 $679.62
90633 1,018 977 $663.43
90680 1,469 1,425 $579.50
90619 34 31 $550.70
99173 3,899 3,435 $515.98
96161 191 148 $274.79
99231 Subsequent hospital care, per day, straightforward or low complexity 39 31 $264.25
92587 14 13 $161.65
95115 166 90 $146.02
36416 310 221 $117.66
97802 918 853 $110.42
90744 1,086 1,020 $84.01
3074F 2,408 2,009 $75.00
92551 3,474 3,240 $65.55
90656 15 14 $50.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 146 135 $44.34
0001A 31 31 $40.00
0002A 50 50 $40.00
99058 55 53 $35.55
81025 12 12 $26.68
1036F 5,577 4,458 $9.54
99177 239 222 $5.04
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 137 129 $1.72
91307 143 119 $0.41
91300 58 54 $0.01
3008F 4,640 3,572 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 56 49 $0.00
90723 40 40 $0.00
99000 12 12 $0.00
1160F 6,514 4,838 $0.00
3078F 2,436 2,031 $0.00
90700 42 41 $0.00
1159F 6,521 4,841 $0.00
3725F 897 646 $0.00
90648 144 143 $0.00
90715 26 24 $0.00
90671 115 102 $0.00
96116 151 137 $0.00
90734 48 47 $0.00
81002 17 13 $0.00
90710 13 13 $0.00